Bachelor in Biomedical Sciences from the Federal University of São Paulo (UNIFESP), with a Master's degree and currently a PhD candidate in Microbiology, Immunology, and Parasitology at UNIFESP. Has research experience in the field of malaria, focusing on antimalarial drug resistance. Works with ex vivo susceptibility assays, molecular genotyping, transcriptomics, and genomics of Plasmodium vivax and P. falciparum. Interests include molecular biology, bioinformatics, and strategies for monitoring parasite drug resistance. (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
For many years chloroquine (CQ) was the main drug against blood stages of malaria parasites. Introduced after World War II, the first reports of chloroquine-resistant Plasmodium falciparum appeared in 1957. Resistant parasites quickly spread to all endemic regions, resulting in the total removal of CQ for the treatment of P. falciparum infections in 2000. The first cases of P. vivax chlor…
| 1 / 1 | Completed scholarships in Brazil |
| Associated processes | |
CV Lattes
ORCID